Results 201 to 210 of about 9,592 (241)

Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection. [PDF]

PLoS Pathog
Akaike Y, Tanaka T, Kasai H, Yamashita A, Matsuura Y, Moriishi K.   +5 more
europepmc   +1 more source

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India. [PDF]

BMC Infect Dis
Bakshi S, Dutta S, Biswas A, Das R, Nath S, Ghosh A, Baskey U, Sadhukhan PC.   +7 more
europepmc   +1 more source

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). [PDF]

Viruses
Di Marco L, Cannova S, Ferrigno E, Landro G, Nonni R, Mantia C, Cartabellotta F, Calvaruso V, Di Marco V.   +8 more
europepmc   +1 more source

Daclatasvir: potential role in hepatitis C [Corrigendum]

, 2014
Lee,Choongho
openalex   +1 more source

Outcomes of Direct-Acting Antivirals Versus Interferon-Based Therapy in Chronic Hepatitis C Infection.

Cureus
Chowdhury R, Rashid W, Singh T, Rehman A, Daterdiwala NF, Mkosi V, Limbu B, Bukhari SA, Ramadhan A, Dabas MM, Shehryar A, Khan R.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Asunaprevir/daclatasvir

Reactions Weekly, 2016
  +9 more sources

Asunaprevir/daclatasvir

Reactions Weekly, 2018
  +8 more sources